Starling Oncology

Starling Oncology

Health Care Providers & Services
The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financial counseling, clinical trials, comprehensive lab testing, and end-of-life counseling. The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services. Majority of revenue is from patients services.

$357M

Market Cap • 11/13/2026

2007

(19 years)

Founded

2021

(5 years ago)

IPO

NASDAQ

Listing Exchange

Flag of United States

United States

Country

Valuation

P/B

—

P/S

0,6

P/EBITDA

—

P/OCF

15,5

P/FCF

19

P/E

—

BVPS

—

EPS

—

Market Cap

Market Cap

357M

EV

422,8M

EV/Revenue

0,7

EV/EBITDA

-29,3

EV/EBIT

-20,1

Payout

Dividend Per Share

0

Dividend Yield

0%

Buyback Yield

-1,8%

Total Yield

-1,8%

Payout

0%

Retained Earnings

-299,4M

Profitability

Gross Margin

16,9%

EBITDA Margin

—

EBIT Margin

—

Net Margin

—

D&A/EBITDA

0%

R&D/Revenue

0%

Capex/Revenue

0,7%

Capex/D&A

64,6%

Capex/OCF

18,5%

SBC/OCF

23,5%

% PPE

17,3%

% Goodwill

3,9%

ROE

143,2%

ROIC

—

Growth

CAGR Op. Income 5Y

32,1%

CAGR Net Income 5Y

60,9%

CAGR EPS 5Y

23,7%

Leverage

N.D./EBITDA

—

Debt/Equity

0%

Current Ratio

1,1

Quick Ratio

0,8

Interest Coverage

—

Premium

Unlock 100% of the data and have immediate access on more than 6.000 companies with updated information!
  • Unrestricted access
  • Unlimited data history
  • Analysis videos
  • Quarterly highlights
  • Customizable financials table
  • Ranking
  • Discussions

...and much more!

Get Premium